Product image of Pantoxon (Ceftriaxone Disodium Salt Hemiheptahydrate) supplied by GNH India

Pantoxon

Active Ingredient:
Ceftriaxone Disodium Salt Hemiheptahydrate
Origin:
EU

Pantoxon (Ceftriaxone Disodium Salt Hemiheptahydrate)

Ceftriaxone, the active ingredient in Pantoxon, is a third‑generation cephalosporin presented as an injectable solution for intramuscular use. It treats a range of serious bacterial infections in adults and children.
GNH India supplies Pantoxon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aesculapius Farmaceutici S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ceftriaxone is a broad‑spectrum third‑generation cephalosporin used to treat serious bacterial infections.

  • Community‑acquired pneumonia: rapid bacterial eradication leading to clinical recovery.
  • Meningitis: penetrates the cerebrospinal fluid to eliminate causative pathogens.
  • Gonorrhea: effective against Neisseria gonorrhoeae, preventing disease progression.
  • Urinary tract infections: clears uropathogens causing uncomplicated and complicated UTIs.
  • Skin and soft tissue infections: resolves cellulitis and wound infections.
  • Intra‑abdominal infections: treats polymicrobial infections within the abdominal cavity.

How It Works

  • Ceftriaxone binds to penicillin‑binding proteins on bacterial cell walls, inhibiting the final stages of peptidoglycan cross‑linking. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis, thereby eliminating susceptible Gram‑positive and Gram‑negative organisms.

Side Effects

Ceftriaxone may cause a variety of adverse reactions ranging from mild to severe.

Common Side Effects

  • Injection site pain: discomfort at the intramuscular injection site.
  • Diarrhea: mild to moderate loose stools.
  • Nausea: feeling of unease or upset stomach.
  • Rash: skin redness or mild eruption.
  • Elevated liver enzymes: transient increase in hepatic transaminases.
  • Transient hyperbilirubinemia: mild rise in bilirubin levels.

Serious or Rare Side Effects

  • Anaphylaxis: severe, potentially life‑threatening allergic reaction.
  • Clostridioides difficile‑associated diarrhea: severe colitis.
  • Stevens‑Johnson syndrome: extensive skin and mucous membrane involvement.
  • Hemolytic anemia: destruction of red blood cells.
  • Thrombophlebitis: inflammation of a vein with clot formation.
  • Renal impairment: acute kidney injury, especially with concomitant nephrotoxins.

Precautions & Warnings

Ceftriaxone requires careful clinical monitoring to ensure safe use.

  • Renal function assessment: adjust use in patients with impaired kidney function.
  • Hepatic monitoring: observe liver enzymes during prolonged therapy.
  • Neonatal dosing: use reduced doses for infants under 28 days.
  • Known hypersensitivity: avoid in patients with documented cephalosporin allergy.
  • Biliary sludging risk: monitor patients with gallbladder disease.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Ceftriaxone can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Calcium‑containing solutions: precipitate formation when mixed intravenously.
  • Bile acid sequestrants: reduce ceftriaxone absorption.
  • Warfarin: may enhance anticoagulant effect, increasing bleeding risk.
  • Aminoglycosides: combined nephrotoxicity potential.
  • Live vaccines: may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Diuretics: may affect electrolyte balance.
  • Antacids: can alter drug excretion.
  • Oral contraceptives: possible reduction in contraceptive effectiveness.
  • Probenecid: decreases renal clearance, raising ceftriaxone levels.
  • Carbapenems: may increase risk of seizures when co‑administered.

Frequently Asked Questions

Pantoxon contains ceftriaxone, a third‑generation cephalosporin antibiotic used to treat serious bacterial infections such as community‑acquired pneumonia, meningitis, gonorrhea, urinary tract infections, skin and soft tissue infections, and intra‑abdominal infections.

Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins, preventing the cross‑linking of peptidoglycan strands. This weakens the cell wall, causing osmotic instability and bacterial lysis, which eradicates susceptible Gram‑positive and Gram‑negative organisms.

The dosage of Pantoxon is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, and renal or hepatic function. The prescriber sets the exact amount and frequency according to clinical guidelines.

Safety data for ceftriaxone in pregnancy are limited, and the drug is classified as pregnancy category unknown. It should only be used if the potential benefit justifies any potential risk to the fetus. Caution is also advised during breastfeeding, as the drug may be excreted in milk.

To order Pantoxon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the team will provide pricing, availability, shipping details (including cold‑chain handling if needed), and import documentation.

Pantoxon (ceftriaxone) offers broad‑spectrum coverage with a long half‑life, allowing once‑daily dosing, which distinguishes it from many penicillins and earlier‑generation cephalosporins that often require multiple daily doses. Its activity against both Gram‑positive and Gram‑negative bacteria makes it a versatile alternative for severe infections.

Pantoxon should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging to maintain stability until it is prepared for intramuscular administration.

Pantoxon is supplied as an injectable solution for intramuscular injection. The medication is administered by a qualified healthcare professional using aseptic technique, typically into a large muscle such as the gluteus maximus, following the dose prescribed by the clinician.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, Stevens‑Johnson syndrome, hemolytic anemia, thrombophlebitis, and renal impairment, especially when combined with other nephrotoxic agents. Immediate medical attention is required if any of these events occur.

Pantoxon should be avoided in individuals with a known hypersensitivity to ceftriaxone, other cephalosporins, or β‑lactam antibiotics. Caution is also advised for patients with severe hepatic or renal impairment, neonates under 28 days, and those with a history of biliary sludging.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ceftriaxone Disodium Salt Hemiheptahydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT